Steinhart Richard I
Insider CIK 1293789 · MELA Chief Financial Officer · ATNM Director · ATOS Director · BTAI Senior VP and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 94,200 | — | $0 | 94,200 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 62,800 | — | $0 | 63,116 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 94,200 | — | $0 | 94,200 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 62,800 | — | $0 | 63,116 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 212 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 26,335 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2026-05-20 | 2026-05-22 | 6,845 | $1.09 | $7.5K | 26,300 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award | 2026-05-12 | 2026-05-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 52,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 33,145 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 15,645 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 247 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 6,645 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 97 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 6,610 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2026-01-01 | 2026-01-05 | 70,000 | — | $0 | 70,282 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 282 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 6,577 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 130 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 6,542 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 317 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 6,509 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 163 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 6,474 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-07-22 | 2025-07-22 | 625 | — | $0 | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-07-22 | 2025-07-22 | 625 | — | $0 | 6,441 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award | 2025-07-22 | 2025-07-22 | 4,375 | — | $0 | 5,816 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 352 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 1,441 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 196 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 1,406 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2025-05-15 | 2025-05-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 70,311 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 72,156 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 18,351 | — | $0 | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 387 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 1,373 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 229 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 1,339 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2025-01-07 | 2025-01-10 | 270,000 | — | $0 | 270,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-12-16 | 2024-12-17 | 372 | $0.36 | $134 | 20,932 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-12-16 | 2024-12-17 | 205 | $0.36 | $74 | 21,157 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 562 | — | $0 | 5,064 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-12-15 | 2024-12-17 | 562 | — | $0 | 21,362 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 2,606 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 20,800 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-10-03 | 2024-10-03 | 7,175 | $0.55 | $3.9K | 20,279 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 27,454 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-09-16 | 2024-09-17 | 356 | $0.69 | $246 | 6,204 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 5,625 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 6,560 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 3,127 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 5,997 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-07-22 | 2025-04-01 | 625 | — | $0 | 625 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2024-06-27 | 2024-07-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-06-17 | 2024-06-18 | 372 | $1.26 | $469 | 5,476 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 6,188 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 5,848 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 3,648 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 5,286 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-04-04 | 2024-04-08 | 1,069 | $2.64 | $2.8K | 4,765 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 6,750 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 5,834 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 4,169 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 3,584 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2023-12-28 | 2023-12-29 | 70,311 | — | $0 | 70,311 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-12-14 | 2023-12-18 | 521 | — | $0 | 4,690 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-12-14 | 2023-12-18 | 521 | — | $0 | 3,063 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-09-14 | 2023-09-18 | 521 | — | $0 | 5,211 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-09-14 | 2023-09-18 | 521 | — | $0 | 2,542 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-06-14 | 2023-06-16 | 521 | — | $0 | 5,732 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-06-14 | 2023-06-16 | 521 | — | $0 | 2,021 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-05-15 | 2023-05-16 | 5,000 | $27.17 | $135.8K | 1,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-05-14 | 2023-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-05-14 | 2023-05-16 | 5,000 | — | $0 | 6,500 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2023-05-04 | 2023-05-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-16 | 32,000 | — | $0 | 32,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-16 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-03-15 | 2023-03-16 | 2,084 | $19.50 | $40.6K | 1,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-03-14 | 2023-03-16 | 2,084 | — | $0 | 6,253 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-03-14 | 2023-03-16 | 2,084 | — | $0 | 3,584 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2022-07-01 | 2022-07-01 | 72,156 | — | $0 | 72,156 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2022-05-14 | 2022-05-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2022-05-13 | 2022-05-16 | 50,000 | — | $0 | 500,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2022-03-14 | 2022-03-16 | 33,350 | — | $0 | 33,350 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2022-03-14 | 2022-03-16 | 8,337 | — | $0 | 8,337 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2021-09-01 | 2021-09-03 | 18,351 | — | $0 | 18,351 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2021-05-14 | 2021-05-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2021-03-25 | 2021-03-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,750 | — | $0 | 80,148 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 3,750 | $48.15 | $180.6K | 1,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 3,750 | $5.55 | $20.8K | 5,250 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2020-08-12 | 2020-08-14 | 8,333 | — | $0 | 8,333 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2020-05-26 | 2020-05-28 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2020-05-15 | 2020-05-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2019-07-12 | 2019-07-16 | 250,000 | $0.23 | $57.5K | 250,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2019-05-17 | 2019-05-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-03 | 2018-12-04 | 500 | $5.20 | $2.6K | 1,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-11-30 | 2018-11-30 | 500 | $5.00 | $2.5K | 1,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-11-29 | 2018-11-30 | 500 | $5.00 | $2.5K | 500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2018-07-13 | 2018-07-17 | 75,000 | $0.78 | $58.5K | 75,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2018-06-27 | 2018-06-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-03-13 | 32,232 | — | $0 | 116,130 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other deriv | 2018-03-06 | 2018-03-08 | 5,250 | $0.50 | $2.6K | 5,250 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other deriv | 2018-03-06 | 2018-03-08 | 1,750 | $0.50 | $875 | 1,750 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other | 2018-03-06 | 2018-03-08 | 7,000 | $0.50 | $3.5K | 9,500 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2017-05-24 | 2017-05-26 | 49,531 | — | $0 | 59,062 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2017-03-14 | 2017-03-16 | 75,000 | $1.39 | $104.2K | 75,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2016-05-18 | 2016-05-19 | 71,484 | — | $0 | 71,484 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2016-04-15 | 2016-04-18 | 75,000 | $1.99 | $149.3K | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2016-04-14 | 2016-04-18 | 2,500 | $2.01 | $5.0K | 2,500 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2015-05-12 | 2015-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2015-02-18 | 2015-03-16 | 25,000 | $3.58 | $89.5K | 25,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2014-05-06 | 2014-05-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | D To issuer | 2014-05-06 | 2014-05-08 | 22,728 | — | $0 | 0 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2014-03-01 | 2014-03-04 | 16,484 | — | $0 | 16,484 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award | 2014-03-01 | 2014-03-04 | 22,728 | — | $0 | 22,728 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2013-12-16 | 2013-12-24 | 49,950 | $6.70 | $334.7K | 49,950 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | A Award deriv | 2013-08-05 | 2013-08-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | A Award deriv | 2013-08-05 | 2013-08-08 | 141,304 | — | $0 | 141,304 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | A Award | 2013-08-05 | 2013-08-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | P Buy | 2013-06-25 | 2013-06-25 | 3,000 | $0.81 | $2.4K | 4,000 | SEC↗ |
| MELA MELA SCIENCES, INC. /NY | A Award deriv | 2013-04-25 | 2013-04-26 | 1,500 | — | $0 | 1,500 | SEC↗ |